These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4211361)

  • 41. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
    Naumann P
    Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771
    [No Abstract]   [Full Text] [Related]  

  • 42. Cephaloridine, laboratory and clinical evaluation.
    Lane RA; Cox F; McHenry M; Quinn EL
    Antimicrob Agents Chemother (Bethesda); 1966; 6():88-95. PubMed ID: 5985310
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study on the dynamics of antimicrobial agents in vivo--cephaloridine and cephalothin].
    Kitamoto O; Fukaya K; Wajima T
    J Antibiot B; 1965 Dec; 18(6):443-6. PubMed ID: 5296407
    [No Abstract]   [Full Text] [Related]  

  • 45. Changing patterns of bacterial resistance in relation to prophylactic use of cephaloridine and therapeutic use of ampicillin.
    Pollock AV; Evans M
    Lancet; 1975 Dec; 2(7947):1251-4. PubMed ID: 53736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of 7 cephalosporins on "Staphylococcus aureus" by the method of population analysis (author's transl)].
    Sirot D; Sirot J; Cluzel R; Joly B
    Pathol Biol (Paris); 1977 Nov; 25(9):605-10. PubMed ID: 341049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Basic and clinical evaluation of cephaloridine and cephalothin in the field of surgery].
    Ishii R; Ishibiki H; Oi H; Tsunekawa Y; Nakamura Y
    J Antibiot B; 1965 Dec; 18(6):479-81. PubMed ID: 5296412
    [No Abstract]   [Full Text] [Related]  

  • 48. Cephaloridine and cephalothin comparative in vitro evaluation.
    Perkins RL; Saslaw S; Hackett J
    Am J Med Sci; 1967 Mar; 253(3):293-9. PubMed ID: 4381476
    [No Abstract]   [Full Text] [Related]  

  • 49. [Present status of bacterial resistance to antibiotics and chemotherapeutic drugs and a tendency towards the development of resistance].
    Fritsche D; Schulz-Stübner A
    Dtsch Med Wochenschr; 1972 Dec; 97(51):1963-8. PubMed ID: 4404874
    [No Abstract]   [Full Text] [Related]  

  • 50. [Compared sensitivities to cephalothin cephaloridine cephalexin and ampicillin of 500 bacterial strains isolated in a hospital].
    Courtieu AL; Sedallian A; Moinard D; Lecluse J
    Pathol Biol (Paris); 1972 Jan; 20(1):43-50. PubMed ID: 4552029
    [No Abstract]   [Full Text] [Related]  

  • 51. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 52. Microbiological studies on cefoperazone.
    Kayser FH
    Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of cephalosporin C on Coombs' test (author's transl)].
    Seiga K; Minakawa M; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1974 Apr; 27(2):128-34. PubMed ID: 4546608
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro studies with Ciba 36278-Ba, a new cephalosporin derivative.
    Russell AD
    Microbios; 1972 Dec; 6(24):221-30. PubMed ID: 4487949
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
    Hall MJ; Westmacott D; Wong-Kai-In P
    J Antimicrob Chemother; 1981 Sep; 8(3):193-203. PubMed ID: 6270051
    [No Abstract]   [Full Text] [Related]  

  • 56. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F
    G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
    Miraglia GJ; Renz KJ; Gadebusch HH
    Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cephaloridine activity on bacterial flora isolated from non-specific bronchopneumonic processes].
    Curci G; Ninni A
    Policlinico Med; 1971; 78(6):284-9. PubMed ID: 5157402
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the clinical aspects of cephalosporins. I. Bacteriological section].
    Breitfellner G
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):174-9. PubMed ID: 4895448
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.